• Policy
• GSK's Shingrix has been granted
• by Lee, Tak-Sun Sep 8, 2021 06:05am

• Policy
• Roche’s Herceptin+Perjeta combo is approved in Korea
• by Lee, Tak-Sun Sep 7, 2021 05:53am

• Policy
• The request for Zolgensma's benefit is growing
• by Lee, Jeong-Hwan Sep 7, 2021 05:53am

• Policy
• Letrozole for ovulation-inducing use is not allowed
• by Lee, Hye-Kyung Sep 7, 2021 05:53am

• Policy
• Insurance benefit denied for 3 Soliris and 1 Ultomiris cases
• by Lee, Hye-Kyung Sep 6, 2021 05:58am

• Policy
• JAK Inhibitors increases heart attack
• by Lee, Tak-Sun Sep 6, 2021 05:58am

• Policy
• The Committee discusses the permission for Mifegymiso
• by Lee, Tak-Sun Sep 5, 2021 08:25pm

• Policy
• GOV to bring 1.5 mil COVID-19 vaccines from Romania
• by Kim, Jung-Ju Sep 3, 2021 06:03am

• Policy
• Eligibility for adjustment applications improved
• by Lee, Hye-Kyung Sep 2, 2021 05:59am

• Policy
• The MOHW objected to improved benefit for Prolia
• by Lee, Jeong-Hwan Sep 1, 2021 05:57am